Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 9(1): 13905, 2019 09 25.
Article in English | MEDLINE | ID: mdl-31554858

ABSTRACT

A single application of Mitomycin C (MMC) is used clinically in ophthalmology to reduce scarring and enhance wound resolution after surgery. Here we show in vitro that a 3-hour MMC treatment of primary and telomerase immortalized human corneal limbal epithelial (HCLE) cells impacts their migration and adhesion. Transient MMC treatment induces HCLE expression of senescence associated secretory factors, cytokine secretion, and deposition of laminin 332 for several days. Transient MMC treatment also reduces migration and deposition of transforming growth factor-ß1 (TGFß1)-stimulated collagen by corneal fibroblasts. Using conditioned media from control and MMC treated cells, we demonstrate that factors secreted by MMC-treated corneal epithelial cells attenuate collagen deposition by HCFs whereas those secreted by MMC-treated HCFs do not. These studies are the first to probe the roles played by corneal epithelial cells in reducing collagen deposition by corneal fibroblasts in response to MMC.


Subject(s)
Cell Movement/drug effects , Cornea/drug effects , Cytokines/metabolism , Epithelial Cells/drug effects , Fibroblasts/drug effects , Mitomycin/pharmacology , Cells, Cultured , Cicatrix/metabolism , Collagen/metabolism , Cornea/metabolism , Epithelial Cells/metabolism , Fibroblasts/metabolism , Humans , Transforming Growth Factor beta1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...